Generic Name and Formulations:
Ganirelix acetate 250mcg per 0.5mL; soln for SC inj.

Company:
Merck & Co., Inc.
Indications for Ganirelix acetate inj:
Inhibition of premature LH surges in women undergoing controlled ovarian hyperstimulation.

Adult:
After initiating FSH on day 2 or 3 of the cycle: 250mcg once daily SC during the mid to late follicular phase. Continue until the day of hCG.

Children:
Not applicable.

Pharmacological Class:
GnRH antagonist.

Contraindications:
Pregnancy (Cat.X). Nursing mothers.

Warnings/Precautions:
Do complete gynecological and endocrinological exam first. Latex allergy.

Adverse Reactions:
Abdominal pain (gynecological), fetal death, headache, ovarian hyperstimulation syndrome, vaginal bleeding, injection site reactions, nausea, GI pain.

How Supplied:
Prefilled syringe—1, 5, 50